Evaluation of Changes in Consumption of Drugs and Substances After Incarceration
COSMOS
1 other identifier
observational
629
1 country
6
Brief Summary
To improve the management and risk reduction, it is essential to understand the evolution of the consumption of psychoactive substances, medicated or not in detention; it does not have at present no data on this subject. This work has as main objective to evaluate the development of substance use terms (goods and consumption practices) by the inmates between the period preceding their incarceration and their fifth month in detention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 27, 2016
CompletedFirst Posted
Study publicly available on registry
July 29, 2016
CompletedJuly 29, 2016
July 1, 2016
Same day
July 27, 2016
July 28, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
change in practices of consumption of psychoactive substances between the period prior to incarceration and detention period
composite endpoint representing the existence of a change in practices of consumption of psychoactive substances between the period prior to incarceration and detention period
Until 5 months
Eligibility Criteria
The eligible study population is incarcerated major subjects. The topics will be selected subjects incarcerated in remand centers participating in the study. All subjects were medical examination, Home Maintenance arriving at their entrance into custody. On this occasion, the medical staff will verify the absence of non inclusion criterion and the subject will be informed orally and via an information sheet that will retain an invitation to respond to an anonymous questionnaire will be sent after him 4 or 5 months of detention (as prisons). He may accept or reject this invitation.
You may qualify if:
- Major subject
- Subject in the fourth or fifth month of incarceration
- Held about agreeing to participate in the study
You may not qualify if:
- Patient refusing to participate
- Patient unable to respond to the questionnaire (major difficulties understanding of the French language)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Angers University Hospital
Angers, 49000, France
Fontenay Le Comte Hospital
Fontenay-le-Comte, 85200, France
La Roche sur Yon Hospital
La Roche-sur-Yon, 85000, France
Laval Hospital
Laval, 53000, France
Le Mans Hospital
Le Mans, 72000, France
Nantes University Hospital
Nantes, 44093, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Caroline VICTORRI-VIGNEAU, Dr
Nantes University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2016
First Posted
July 29, 2016
Study Start
January 1, 2015
Primary Completion
January 1, 2015
Study Completion
July 1, 2016
Last Updated
July 29, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share